| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84015-930-60 | 84015-930 | HUMAN PRESCRIPTION DRUG | PALSONIFY | PALTUSOTINE | TABLET, FILM COATED | ORAL | 20250925 | N/A | NDA | NDA219070 | Crinetics Pharmaceuticals, Inc. | PALTUSOTINE HYDROCHLORIDE | 30 mg/1 | 60 TABLET, FILM COATED in 1 BOTTLE (84015-930-60) |
| 84015-920-60 | 84015-920 | HUMAN PRESCRIPTION DRUG | PALSONIFY | PALTUSOTINE | TABLET, FILM COATED | ORAL | 20250925 | N/A | NDA | NDA219070 | Crinetics Pharmaceuticals, Inc. | PALTUSOTINE HYDROCHLORIDE | 20 mg/1 | 60 TABLET, FILM COATED in 1 BOTTLE (84015-920-60) |